Drug pricing, budget cuts, tariffs and other shifts under the Trump administration undermine the biopharma and healthcare ...

As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical ...

The Innovation Center of NanoMedicine has summarized the results of its collaborative research with Professor Kanjiro ...

BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I ...

The latest research study released by Coherent Market Insights on "Immune Cell Therapy Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and ...

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Gene therapies have ridden investor mania to huge valuations but commercialization challenges have pushed market caps to the ...

Navigating the world of therapy for your teen or tween can feel like a big, intimidating task. You might wonder: Where do I ...

BOSTON, June 9, 2025 /PRNewswire/ -- Taiwan Cell Manufacturing Company (tcmc), a leading Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy (CGT), will showcase ...

It is anticipated that the global biomarker testing market will experience rapid growth, with a valuation of approximately USD 122.8 billion by 2033, and a compound annual growth rate (CAGR) of 10.4% ...

On Tuesday, 03 June 2025, Bio-Techne (NASDAQ:TECH) presented at the 45th Annual William Blair Growth Stock Conference. CEO Kim Kelderman outlined a strategic vision focused on innovation and ...